Institutional Ownership Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN). We have compiled data on the 184 institutions that hold shares in the stock, with a total of 82.7 Million shares, which have been reported (via 13F filing form) to have a value of $1.64 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
5,380,449
shares
|
$109 Million
2.67% of portfolio
|
Q1 2025
Added 18.96%
|
|
|
Commodore Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
4,875,000
shares
|
$98.9 Million
6.35% of portfolio
|
Q2 2025
Added 35.42%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,773,622
shares
|
$96.9 Million
0.0% of portfolio
|
Q2 2024
Added 25.21%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
4,508,508
shares
|
$91.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.2%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
4,427,927
shares
|
$89.8 Million
7.39% of portfolio
|
Q2 2025
Reduced 5.79%
|
|
|
Vr Adviser, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
3,882,709
shares
|
$78.8 Million
10.75% of portfolio
|
Q3 2024
Added 0.0%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Aug 14, 2025 Q2 2025 |
3,459,913
shares
|
$70.2 Million
14.83% of portfolio
|
Q2 2025
Added 0.41%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,895,265
shares
|
$58.7 Million
0.0% of portfolio
|
Q2 2025
Added 71.51%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
2,842,925
shares
|
$57.7 Million
2.38% of portfolio
|
Q2 2025
Added 1.79%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,741,576
shares
|
$55.6 Million
1.79% of portfolio
|
Q2 2025
Added 30.86%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,553,426
shares
|
$51.8 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.89%
|
|
|
Novo Holdings
Hellerup, G7 |
Aug 14, 2025 Q2 2025 |
2,380,000
shares
|
$48.3 Million
2.9% of portfolio
|
Q2 2025
Added 5.76%
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Aug 14, 2025 Q2 2025 |
2,257,010
shares
|
$45.8 Million
0.54% of portfolio
|
Q2 2025
Added 9.5%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
1,944,020
shares
|
$39.4 Million
0.01% of portfolio
|
Q2 2025
Reduced 3.84%
|
|
|
Eversept Partners, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,902,539
shares
|
$38.6 Million
2.68% of portfolio
|
Q2 2025
Added 38.1%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,744,406
shares
|
$35.4 Million
0.25% of portfolio
|
Q2 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,740,614
shares
|
$35.3 Million
0.0% of portfolio
|
Q2 2025
Added 1.17%
|
|
|
Loomis Sayles & CO L P
|
Aug 13, 2025 Q2 2025 |
1,338,472
shares
|
$27.2 Million
0.02% of portfolio
|
Q2 2025
Reduced 2.33%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
1,298,825
shares
|
$26.4 Million
2.43% of portfolio
|
Q2 2025
Added 22.01%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
1,265,754
shares
|
$25.7 Million
0.02% of portfolio
|
Q2 2025
Added 1.36%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
1,207,871
shares
|
$24.5 Million
0.02% of portfolio
|
Q2 2025
Added 11.42%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,108,586
shares
|
$22.5 Million
0.03% of portfolio
|
Q2 2025
Reduced 0.54%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,061,517
shares
|
$21.5 Million
0.03% of portfolio
|
Q2 2023
Added 1.78%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
982,576
shares
|
$19.9 Million
2.91% of portfolio
|
Q4 2024
Reduced 41.45%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
899,825
shares
|
$18.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 26.91%
|